Maruho Report 202361925American-style pharmacy “Maruho Pharmacy” opened in Osaka1939Maruho Shouten Co., Ltd. was established1940Constructed a plant for production1943Company was temporarily dissolved for the war effort1949Maruho Shouten Co., Ltd. was refoundedSince 1930Working to reliably provide patients with medicinesTo build a more reliable supply network, Maruho has focused on its domestic medicine production business. With the release of cough syrup Co-fu Syrup in 1931 and the mosquito repellent cream Moskiton the following year, Maruho achieved success in domestically producing foreign products and helped improve people’s daily lives.1951Working for health, the source of “life”Jiro Takagi, who joined Maruho in 1950, was entrusted by Koba to manage Maruho. Based on his experience during the war, Takagi seriously believed in the value of “life,” pursued the public good of companies, endured the difficult postwar times, and instilled the “faith” that has taken root in Maruho today1952Entry into the springs businessTo continue business in the unstable post-war environment, Maruho entered into the springs business as springs could be produced domestically. Maruho Hatsujyo Kogyo Co., Ltd. was established in 1954, and has maintained a close collaborative relationship with other companies in the Maruho Group for more than 70 yearsSince 1950Achieving steady growth in orthopedics, surgery, and dermatologyWith products such as intravenous agent for asthma Asthmolysin, hemorrhoid treatment ointment Posterisan Forte, transdermal multiple anti-inflammatory ointment Mobilat, and articular cartilage protective agent Arteparon, Maruho has achieved steady growth in establishing markets for high-quality drugs by providing useful information to those in orthopedics, surgery, and dermatology.1965Company name was changed to Maruho Co., Ltd.1972Hikone Plant (Shiga Prefecture) was completed1997Headquarters was relocated to its current site (Nakatsu, Kita-ku, Osaka)1998Research functions were consolidated in Kyoto Research Park (Currently: Kyoto R&D Center Drug Development Laboratories, Drug Discovery Research Laboratories)Since 1990Reaching new growth stages by leveraging formulation technologiesMaruho added the additional indication of asteatosis to its Hirudoid cream, relaunching the product as a skin moisturizer. As lifestyles change and the importance of skincare grows, Hirudoid has grown into a product that continues to help many people.Stable supplyAppropriate information provisionFormulation technologyfor topical drugs
元のページ ../index.html#7